Summary: Wachovia MERLOTS (Series 2007D75), Pennsylvania Dec 07

  • ID: 1929864
  • December 2007
  • Region: Pennsylvania
  • Standard & Poors
1 of 3

Wachovia MERLOTS, Pa.'s series 2007D75, related to District of Columbia's series 2007C GO bonds, are rated 'AAA/A-1+'. The long-term component of the rating is based on the FSA-insured underlying bond. The short-term component of the rating is based on the liquidity facility provided by Wachovia Bank N.A. until Dec. 19, 2008. The stable outlook is based on the bond insurer, FSA....

Companies mentioned in this report are:
- District of Columbia

Action: New Rating
Action: Outlook: Stable

Standard and Poors RatingsXpress Credit Research provides in-depth coverage of international corporates, financial institutions, insurance companies, utilities, sovereigns and structured finance programs. RatingsXpress Credit Research lets users determine the credit rating of holdings and identify key factors underlying an issuer's creditworthiness, distinguishes the different risk exposures for new and existing deals, and provides an understanding of how their analysts interpret key regulatory, political and environmental events and their economic impact.

This product consists of a Summary Analysis: Bi-annual (at least). An abbreviated analysis containing Standard & Poor's issuer credit ratings as of the time the article was published. The analysis includes a rating rationale - the basis on which the rating was assigned - and an outlook section if the issuer is not on CreditWatch. Financial statistics are not included.

Note: Product cover images may vary from those shown
2 of 3

- District of Columbia

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: This Credit Rating Report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.